Abiopharma

🔍 Ghaffarian Kamal Seyed (Director)

Company: Intuitive Machines, Inc. (LUNR)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 267,448 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 3,762,216.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 267,448 shares of Class C Common Stock (Direct)
  Date: 2026-08-10 | Code: D | equity_swap_involved: 0 | shares_owned_after: 34,362,449.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 248,784 shares of Class A Common Stock at $16.1338 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,513,432.00 | transaction_form_type: 4 | Footnotes: F4, F5, F2
• Sold 18,664 shares of Class A Common Stock at $16.6825 per share (Direct)
  Date: 2026-08-10 | Code: S | equity_swap_involved: 0 | shares_owned_after: 3,494,768.00 | transaction_form_type: 4 | Footnotes: F4, F6, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-10 | Code: H | shares_owned_after: 153,526.00
• Sold 267,448 shares of Common Units (Derivative)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 34,362,449.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1, F1, F2

Footnotes:

• F1: The Common Units of Intuitive Machines, LLC may be redeemed for shares of the Issuer's Class A Common Stock on a one-to-one basis at the discretion of the holder. The Common Units do not expire. Upon the redemption of any Common Units, a number of shares of Class C Common Stock equal to the number of Common Units that are redeemed will automatically be cancelled for no consideration.
• F2: Following the transactions reported herein, represents (i) 2,241,121 Common Units and shares of Class C Common Stock held of record by GM Enterprises, LLC and (ii) (x) 32,121,328 Common Units and shares of Class C Common Stock and (y) 3,494,768 shares of Class A Common Stock held of record by Ghaffarian Enterprises, LLC.
• F3: Kamal Ghaffarian is the sole managing member of GM Enterprises, LLC and is the sole trustee of a revocable trust that is the sole member of Ghaffarian Enterprises, LLC. As a result, Dr. Ghaffarian may be deemed to share beneficial ownership of the securities reported herein, but disclaims beneficial ownership except to the extent of his pecuniary interest therein.
• F4: The sales reported herein were effected pursuant to a Rule 10b5-1 plan adopted by Ghaffarian Enterprises, LLC on December 4, 2025.
• F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.62 to $16.61, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
• F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.62 to $16.81, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.